Nuclear Medicine Methods for Evaluation of Abnormal Parathyroid Glands in Patients with Primary and Secondary Hyperparathyroidism

Open access


Considered rare disease in the past, primary hyperparathyroidism (PHPT) has dramatically increased in incidence over the past thirty years with the introduction of routine calcium measurements; it is now approximately 42 per 100 000 persons. By far, the most common lesion found in patients with PHPT is the solitary parathyroid adenoma, occurring in 85%-90% of patients, while in the rest 10%- 15% primary hyperplasia of the parathyroid glands is present. Currently, the most widely used surgical approach is minimally invasive parathyroidectomy which is associated with less post-surgery complications and shorter operation time. To be successful this procedure needs to rely on a precise preoperative localization of the abnormal parathyroid glands, hence preoperative parathyroid imaging gained so large importance. The rationale for locating abnormal parathyroid tissue prior to surgery is that the glands can be notoriously unpredictable in their location. There is a general consensus that the best imaging procedure identifying abnormal parathyroid glands is the preoperative scintigraphy with 99mTc-sestamibi or 99mTc-tetrofosmin. It is characterized with high sensitivity and specificity exceeding those of ultrasound, CT or MRI. Combining scintigraphy with the other imaging techniques increases the precision for topic localization.

1. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc 2002;77(1):87-91.

2. Ruda JM, Hollenbeak C, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132(3):359-72.

3. Russell CF, Laird JD, Ferguson WR. Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach? World Surg 1990;14(3);406-9.

4. Harnsberger HR, Osborn AG, Ross J, et al. Thyroid gland and parathyroid glands. In: Harnsberger HR, Osborn AG, Macdonald A, Ross J, eds. Diagnostic and surgical imaging anatomy: brain, head and neck, spine. Salt Lake City, Utah: Amirsys; 2006.

5. Dufour DR, Wilkerson SY. Factors related to parathyroid weight in normal persons. Arch Pathol Lab Med 1983;107(4):167-72.

6. Alveryd A. Parathyroid glands in thyroid surgery. I. Anatomy of parathyroid glands. II. Postoperative hypoparathyroidism - identifi cation and autotransplantation of parathyroid glands. Acta Chir Scand 1968;389:1-120.

7. Wang C, Mahaffey JE, Axelrod L, et al. Hyperfunctioning supernumerary parathyroid glands. Surg Gynecol Obstet 1979;148:711-4.

8. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery 1984;95:14-21.

9. DeLellis RA. Surgical pathology of the parathyroid glands. In: Randolph G, ed. Surgery of the thyroid and parathyroid glands. St. Louis, Mo: Elsevier; 2003;571-7.

10. De Feo MI, Colagrande S, Biagini C, et al. Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;241(2):393-402.

11. Waldorf JC, van Heerden JA, Gorman CA, et al. (75 Se) Selenomethionine scanning for parathyroid localization should be abandoned. Mayo Clin Proc 1984;59:534-7.

12. Ferlin G, Borsato N, Camerani M, et al. New perspectives in localizing enlarged parathyroids by technetium - thallium subtraction scan. J Nuc Med 1983;24(5):438-41.

13. Coakley AJ, Kettle AG, Wells CP, et al. 99mTcsestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989;10(11):791-4.

14. Arbab As, Koizumi K, Toyama K, et al. Uptake of technetium-99m-tetrofosmin, technetium-99m- MIBI and thallium-201 in tumor cell lines. J Nuc Med 1996;37(10):1551-6.

15. O’Donety MJ, Kettle AG, Wells CP, et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1998;33:313-8.

16. Lee VS, Spritzer CE, Coleman RE, et al. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. Am J Roentgenol 1996;167(6):1555-62.

17. Moka D, Voth E, Dietlein T, et al. Technetium 99m- MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000;128(1):29-35.

18. Carpentier A, Jeannotte S, Verreault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium - 99 m - MIBI uptake and oxyphill cell content. J Nucl Med 1998;39(8):1441-4.

19. Benard F, Lefebre B, Beuvon F, et al. Rapid washout of technetium - 99 - MIBI from a large parathyroid adenoma. J Nucl Med 1995;36(2):241-3.

20. Bergenfelz A, Tennvall J, Valdermarsson S, et al. Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery 1997;121(6):601-5.

21. Casas AT, Burke GJ, Sathyanarayana S, et al. Prospective comparison of technetium-99m-sestamibi/ iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Am

J Surg 1993;166(4):369-73.

22. Bhatnagar A, Vezza PR, Bryan JA, et al. Technetium- 99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nuc Med 1998;39:1617-20.

23. Chudzinski W, Niderla J, Lasiecka Z, et al. P-glycoprotein expression infl uences the result of 99mTc- MIBI scintigraphy in tertiary hyperparathyroidism. Int J Mol Med 2005;16:215-9.

24. Grzela T, Chudzinski W, Lazarczyk M, et al. Persisted/ recurrent hyperparathyroidism associated with development of multi-drug resistance phenotype and proliferation of parathyroid transplants. Int J Mol Med 2004;14:559-99.

25. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99msestamibi (double-phase study). J Nucl Med 1992;33(10):1801-7.

26. Casara D, Rubello D, Piotto A, et al. 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MiBi and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300-4.

27. Benard F, Lefebvre B, Beuvon F, et al. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995;36:241-3.

28. Casara D, Rubello D, Piotto D, et al. 99mTc- MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27(9):1300-4.

29. Ozkaya M, Elboga E, Sahin E, et al. Evaluation of conventional imaging techniques on preoperative localization in primary hyperparathyroidism. Bosn J Basic Med Sci 2015;15(1):61-6.

30. Pons F, Torregrosa JV, Vidal-Sicart S, et al. Preoperative parathyroid gland localization with 99Tcsestamibi in secondary hyperparathyroidism. Eur J Nuc Med 1997;24(12):1494-8.

31. Ishibashi M, Nishida H, Okuda S, et al. Localization of parathyroid glands in hemodialysis patients using Tc-99m Sestamibi imaging. Nephrol 1998;78:48.

32. Walgenbach S, Dutkowski P, Andreas J, et al. [99mTc-MIBI-scintigraphy before parathyroid surgery?]. Zentralbl Ihir 2000;124(3):214-9 [German].

33. Mimura Y, Kanauchi H, Ogawa T, et al. Review of 41 patients operated on for primary hyperparathyroidism. Biomed Pharmacother 2000;54(Suppl. 1):72-6.

34. Kusakabe K, Oshima M, Takami H, et al. [Evaluation of clinical utility of 99mTc-MIBI scintigraphy in the localization of hyperfunctioning parathyroid lesions in patients with hyperparathyroidism--a report of multicenter phase III clinical trials]. Kaku Igaku. 1998;35(9):887-99 [Japanese].

35. Rothmund H, Diethelm J, Brunner C, et al. Diagnosis and surgical treatment of mediastinal parathyroid tumors. Ann Surg 1976;183(2):139-45.

36. Rubello D, Mazzarollo R, Casara D. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 2000;27(4):431-40.

37. Takebayashi S, Hidai H, Chiba T, et al. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 1999;40(11):1792-7.

38. Torregrosa JV, Fernandez-Cruz L, Canalejo A, et al. 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000;24(11):1386-90.

39. Hung GU, Wu HS, Tsai SC, et al. Recurrent hyperfunctioning in parathyroid gland demonstrated on radionuclide imaging and an intraoperative gamma probe. Clin Nucl Med 2000;25(5):348-50.

40. Lomonte C, Buonvino N, Selvaggiolo M, et al. Sestamibi scintigraphy, topography, and histopathology of parathyroid glands in secondary hyperparathyroidism. Am J Kidney Dis 2006;48(4):638-44.

41. Nichols KJ, Tronco GG, Palestro CJ. Infl uence of multigland parathyroid disease on 99m Tc-sestamibi SPECT/CT. Clin Nucl Med 2016;431(4):282-8.

42. Olaizola I, Zingrafe J, Heuguerot C, et al. [99mTc]- Sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephrology Dialysis Transplantation 2000;15(8):1201-6.

43. Fröberg AC, Valkema R, Bonjer HJ, et al. 99mTctetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy? Eur J Nucl Med Mol Imaging 2003;30:193-6.

44. Hiromatsu Y, Ishibashi M, Nishida H, et al. Technetium- 99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism. Intern Med 2000;39(2):101-6.

45. Vallejos V, Martin-Comin J, Gonzalez MT, et al. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands. Lin Nucl Med 1999;24(12):959-64.

46. Gallowitsch HJ, Mikosch P, Kresnik E, et al. Technetium A 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Invest Radiol 1997;32(8)459-65.

47. Garcheva M, Kostadinova M, Stoynova I, et al. [Comprehensive diagnostics of primary hyperparathyroidism using subtraction planar scintigraphy and SPECT.] Rengenologia y radiologia 2009;48(Suppl. 09):40 [Bulgarian].

48. Mluchkov N, Palashev Y. [99m-TC-MIBI scintigraphy in patients with clinical and laboratory evidence of hyperparthyroidism.] Rengenologia y radiologia 2003;Suppl. 03:76 [Bulgarian].

49. Kovacheva R, Radeva M, Kirilov G, et al. [Diagnostic value of high frequency colour Dopler sonography and 99m-TC-MIBI scintigraphy in primary and secondary hyperparathyroidism.] Rengenologia y radiologia 2004;3:188 [Bulgarian].

50. Suh YJ, Choi JY, Kim SJ, et al. Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single gland primary hyperparathyroidism. Otolaryngol Head Neck Surg 2015;152(3):438-43.

Folia Medica

The Journal of Medical University-Plovdiv

Journal Information

CiteScore 2018: 0.587

SCImago Journal Rank (SJR) 2018: 0.311


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 262 172 23
PDF Downloads 188 139 21